Follicular Lymphoma

Reduced Intensity Salvage Allo-HCT Effective for Follicular Lymphoma

Reduced Intensity Salvage Allo-HCT Effective for Follicular Lymphoma

By

Reduced intensity allogeneic hematopoietic cell transplantation (HCT) is an effective salvage treatment strategy in patients with follicular lymphoma.

Study Identifies Factors Influencing Advanced Follicular Lymphoma Outcomes

Study Identifies Factors Influencing Advanced Follicular Lymphoma Outcomes

By

Induction therapy with lenalidomide plus rituximab may result in control that is comparable to rituximab plus chemotherapy for the initial treatment.

Early relapse of follicular lymphoma may increase risk of death

Early relapse of follicular lymphoma may increase risk of death

Early relapse of follicular lymphoma could be carefully considered when making decisions about treatment for these patients.

Managing follicular lymphoma

Managing follicular lymphoma

Changes in how follicular lymphoma is managed have led to substantial improvement in prognosis and over all survival for patients with the disease.

New treatment regimens improving outcomes for follicular lymphoma

New treatment regimens improving outcomes for follicular lymphoma

Vaccines and monoclonal antibodies are promising new treatments for patients with follicular lymphoma.

Watchful waiting strategy OK in low-tumor burden follicular lymphoma

Watchful waiting strategy OK in low-tumor burden follicular lymphoma

Compared with rituximab, an initial watch-and-wait strategy is not detrimental in select patients.

Stem cell treatment does not improve overall survival in follicular lymphoma

High-dose chemotherapy combined with autologous stem cell transplantation did not improve overall survival in previously untreated adult patients with follicular lymphoma.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs